The future of the life sciences industries: aftermath of the global recession
A Deloitte whitepaper developed in cooperation with the Economist Intelligence Unit (EIU). The findings and views expressed in this report are drawn from a global survey and individual interviews conducted with industry leaders.
© 2010 Deloitte
The Future of Industrial Biorefineries
A white paper edited and authored by Sir David King, Director, Smith School of Enterprise and the Environment, University of Oxford, United Kingdom, with co-authors and contributions from O. R. Inderwildi and Alex Williams.
© 2010 World Economic Forum
The German Biotech Industry 2010 - Facts and Figures
Results of the company survey carried out at the beginning of 2010 by the information platform biotechnologie.de on behalf on the Federal Ministry of Education and Research.
© 2010 biotechnologie.de
Regenerative Medicine in Germany
Overview about research, research centers, the regulatory framework and funding in the field of regenerative medicine in Germany.
© 2010 biotechnologie.de
Nanotechnology in Regenerative Medicine
This report provides a brief overview of some of the key developments and approaches in regenerative medicine, together with profiles of some selected companies operating in the field.
© 2010 ObservatoryNANO
Nanotechnology & Therapeutic Delivery
This report examines some of the opportunities that the application of nanotechnology may offer in the field of drug delivery and provides examples of companies known to be developing nanoscale drug delivery systems.
© 2010 ObservatoryNANO
The new science of personalized medicine
Personalized medicine is a disruptive innovation that will require the development
of new business models, particularly for health industry players. To compete in this market, organizations will need new approaches, new relationships, and new ways of thinking.
© 2009 PricewaterhouseCoopers
Green Biotechnology Manifesto
The authorisation of cultivation and use of agricultural biotechnology
products is facing a number of substantial hurdles. The Manifesto aims to highlight the five main problem areas in need of urgent attention and action and to indicate solutions to these problems.
© 2009 EuropaBio
The Bioeconomy to 2030: Designing a Policy Agenda
The report, The Bioeconomy to 2030: Designing a Policy Agenda, is the outcome of an interdisciplinary foresight project by the OECD on the bioeconomy. It provides a broad-based analysis of future developments in the three sectors where biotechnology has the greatest potential impact: agriculture, health and industry. It also explores the implications of developments in these sectors for the economy and society over the next two decades and develops a policy agenda.
© 2009 OECD